Skip to main content

and
  1. No Access

    Chapter

    Clinical Application of iPSC-Derived Cardiomyocytes in Patients with Advanced Heart Failure

    Restoration of damaged cardiac tissues via supplementation with functional cardiomyocytes is an ideal medical treatment for advanced heart failure. Because human induced pluripotent stem cells (hiPSCs) can the...

    Jun Fujita, Shugo Tohyama, Hideaki Kanazawa in Advanced Technologies in Cardiovascular Bi… (2022)

  2. Article

    Open Access

    Toward the realization of cardiac regenerative medicine using pluripotent stem cells

    Heart transplantation (HT) is the only radical treatment available for patients with end-stage heart failure that is refractory to optimal medical treatment and device therapies. However, HT as a therapeutic o...

    Yoshikazu Kishino, Jun Fujita, Shugo Tohyama, Marina Okada in Inflammation and Regeneration (2020)

  3. Article

    Open Access

    Cryoinjury-induced acute myocardial infarction model and ameroid constrictor-induced ischemic heart disease model in adult micro-mini pigs for preclinical studies

    Coronary artery diseases (CAD) are the most commonly occurring disorders in the developed countries. Development of new therapeutics and their success in clinical studies require confirmation of therapeutic ef...

    Akinori Hirano, Jun Fujita, Hideaki Kanazawa in Translational Medicine Communications (2017)